Investors in Sarepta Therapeutics Inc (Symbol: SRPT) saw new options become available today, for the April 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down ...
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, ...
Shares of Solid Biosciences SLDB have rallied 59.9% in the past month. The stock price increase was mainly due to positive initial data, announced in mid-Feb, from the early to mid-stage study of ...
Oppenheimer Asset Management Inc. decreased its stake in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 8.5% during the fourth quarter, HoldingsChannel.com reports. The ...
Some of Massachusetts’ largest life sciences employers, as well as smaller biotechs, increased their headcount in 2024, ...
NasdaqGS:SRPT Earnings and Revenue History March 7th 2025 A Closer Look At Sarepta Therapeutics' Earnings. In high finance, the key ratio used to measure how well a company conver ...
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the therapeutics industry, including Sarepta Therapeutics (NASDAQ:SRPT) and its peers. Over the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback